PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

41,479 stories, page 450 of 692

Advanced search
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Notice of Public Data Asset Release Under the Open, Public, Electronic, and Necessary (OPEN) Government Data Act

In accordance with Title II of the Foundations for Evidence- Based Policymaking Act of 2018, known a...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Availability of Draft Toxicological Profile for Xylene; Extension of Comment Period

On May 5, 2026, the Agency for Toxic Substances and Disease Registry (ATSDR), within the Department...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem

American Radiolabeled Chem has applied to be registered as a bulk manufacturer of basic class(es) of...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Revocation of the Color Additive Listing for Use of Orange B on Casings or Surfaces of Frankfurters and Sausages

The Food and Drug Administration (FDA or we) is issuing an order to repeal the color additive regula...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Proposal To Revoke the Color Additive Listing for Use of Citrus Red No. 2 on the Skins of Mature Oranges

The Food and Drug Administration (FDA or we) is proposing to issue an order that would repeal the co...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Advisory Council on Alzheimer's Research, Care, and Services; Meeting

This notice announces the public meeting of the Advisory Council on Alzheimer's Research, Care, and...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

FDA's Strategy Document on Facilitating Chemistry, Manufacturing, and Controls Readiness for Products With Accelerated Clinical Development

The Food and Drug Administration (FDA or Agency) is announcing the publication of FDA's Strategy Doc...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Medicaid Program; Amending the Indirect Hold Harmless Threshold of Health Care-Related Taxes

This proposed rule would revise standards for determining whether an indirect hold harmless arrangem...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Rescinding Guidelines for Eliminating Discrimination and Denial of Services on the Basis of Race, Color, National Origin, Sex, and Handicap in Vocational Education Programs

The U.S. Department of Health and Human Services (HHS or the Department) rescinds the Guidelines for...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Prospective Grant of an Exclusive Patent License: RXFP1 AGONISTS

The National Center for Advancing Translational Sciences, an institute of the National Institutes of...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Advisory Committee; Peripheral and Central Nervous System Drugs Advisory Committee; Termination and Reestablishment

The Food and Drug Administration (FDA) is announcing the termination and reestablishment of the Peri...

Federal RegisterOriginal source
🇫🇷Devicesessilorluxottica.comTier 1 · Company source

Protecting a Mediterranean Lifeline in Partnership with One Ocean Foundation

EssilorLuxotticaOriginal source
🌍Industrybbbiotech.chTier 1 · Company source

13 Mar, 2026VIDEOWhy biotech is becoming attractive to investors againFind out more

Why biotech is becoming attractive to investors again The “biotech winter” is over. Momentum is retu...

BB BiotechOriginal source
🇺🇰Industryastrazeneca.comTier 1 · Company source

Etcamah (camizestrant) in combination with a CDK4/6 inhibitor approved in the EU for 1st-line advanced ER-positive breast cancer

AstraZeneca NewsOriginal source
🌍Regulatoryafro.who.intTier 1 · Regulatory source

24 July 2026 News ReleaseWHO joins Uganda to celebrate 90 years of the Uganda Virus Research Institute

The World Health Organization joined the Government of Uganda and partners in celebrating the 90th a...

WHO AFROOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: brivaracetam

Official structured record identifier: bdbb6756-654c-46f1-a85c-7d5d1a89685a.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lactulose

Official structured record identifier: 72ac130a-de85-464d-9e9b-05cac0c54db1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Naltrexone Hydrochloride

Official structured record identifier: 57439bad-00f0-5696-e063-6294a90a2ea5.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Hydrochlorothiazide

Official structured record identifier: 57436cfa-9b94-89bf-e063-6394a90aa264.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Warfarin Sodium

Official structured record identifier: 541c9a70-adaf-4ef3-94ba-ad4e70dfa057.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: gadobutrol

Official structured record identifier: 4ea8ae43-22ca-40c0-be72-c91a321cafd1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Estriol Cream

Official structured record identifier: 4deadcb6-0d46-bdd7-e063-6294a90a26d7.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Paroxetine

Official structured record identifier: 4cb9dc05-adb8-4c88-ad40-af8c0df1cafd.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: allergy relief

Official structured record identifier: 41f8fc1d-2d14-48da-a233-23e9c11296d9.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Fresh Scent PROTECTIVE BABY

Official structured record identifier: 3f33c62c-43ec-4576-a24d-bd5de07e74d2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Azithromycin

Official structured record identifier: 3b7e16b1-9a3c-4e3a-8411-841a708afe45.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SKINSUIT FACE SPF 50

Official structured record identifier: 389fc528-fda5-485a-ab37-f99fcf3ed0b3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 DARK DEEP

Official structured record identifier: 360ceb90-bec6-4fec-820a-a4d65008b872.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: COLDTAC Plus

Official structured record identifier: 3496866c-682f-420b-bfdb-64ecebbf70a2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Lamotrigine

Official structured record identifier: 346f8af3-b850-48e4-bd6e-82ecafca86d2.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: HYDROXYZINE HYDROCHLORIDE

Official structured record identifier: 30b6f7b3-b620-961a-e063-6394a90a487b.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Prednisolone Acetate

Official structured record identifier: 3011a244-24a4-46ef-979a-b5d9e7076246.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Orajel Kids Superman

Official structured record identifier: 2b47af33-32d4-7c06-e063-6394a90a2f33.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: DICLOXACILLIN SODIUM

Official structured record identifier: 270c0839-c30c-475d-a505-e70855652c9e.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Younique Bare You BB Tinted Moisturizer Sunscreen Broad Spectrum SPF-30 DARK

Official structured record identifier: 2173666b-6c72-449d-9f40-098ea174f3e1.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: unspecified product

Official structured record identifier: 13162448-1148-392b-e063-6394a90a4ebb.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: PRENATE Restore

Official structured record identifier: 1076ba9a-0168-492f-ba9b-99fa02186092.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: WASKYRA

Official structured record identifier: 106880df-7a30-4a0f-9e16-9f20fcc7d138.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: SOLU-MEDROL

Official structured record identifier: 0cb0ba76-067f-46c4-a5d8-b585d5ecafe3.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: PNV-DHA

Official structured record identifier: 038fe2e7-dc16-485c-b5fb-746db7231347.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: Divalproex Sodium

Official structured record identifier: 0339e27d-3dbf-4c37-a14e-f53557c08e19.

openFDA Drug LabelsOriginal source
🇺🇸Regulatoryopen.fda.govTier 1 · Regulatory source

Drug label update: amoxicillin and clavulanate potassium

Official structured record identifier: 00b86913-50c8-443f-8467-f4f499d358af.

openFDA Drug LabelsOriginal source
🇸🇬Industryir.wavelifesciences.comTier 1 · Company source

Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026

Wave Life SciencesOriginal source
🇺🇸Industryir.unither.comTier 1 · Company source

United Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directors

United Therapeutics (IR)Original source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Pembrolizumab in advanced acral lentiginous melanoma: final results of a single-centre, open-label, phase II trial in an East Asian population

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Diagnostic Performance of Fluorescence-Based Rapid On-Site Specimen Evaluation for Helicobacter pylori Antimicrobial Susceptibility Testing Before and After Algorithm Optimization: A Two-Round Comparative Study

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Development and Validation of a Prognostic Model Based on Postoperative Recurrence-Related Genes for Lung Adenocarcinoma

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Development of a DoE-Driven QbD-Based Stability-Indicating HPTLC Method for determination of PBC in Bulk and Formulation with Multi-Stress Forced Degradation Assessment

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Tivozanib versus Sorafenib as Subsequent-Line Therapy for Advanced Renal Cell Carcinoma: A Cost-Effectiveness Analysis from a US Healthcare Perspective.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Ciprofol versus Propofol Combined with Alfentanil for Respiratory Adverse Events in Overweight Patients Undergoing Painless Gastroscopy: A Randomized Controlled Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Simultaneous Quantification of Mycophenolic Acid and Its Glucuronide Metabolite in PBMCs from Kidney Transplant Recipients by LC-MS/MS.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A Comprehensive Review of Phosphodiesterases 4 (PDE4) Inhibitors in Clinical Trials.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A phase II basket trial of DART SWOG S1609: the salivary gland tumor cohort.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

STENTYS Xposition S in the treatment of chronic total artery occlusion (SXS-CTO trial).

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

pH-responsive chitosan based hydrogels for the simultaneous delivery of atorvastatin calcium and ezetimibe.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Clozapine for Severe Treatment-Resistant Disruptive Behaviors in Youth with Autism Spectrum Disorder: A Prospective Real-World Interventional Study.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Oncology drug development in the UK: analysis of the past 25 years and focus on the 2026 reboot of the clinical trial regulatory framework.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

A Nurse-Led Multicomponent Self-Management Intervention for Patients With Cancer-Related Pain: A Randomized Controlled Trial.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Outcome Measures and ID-COSM Reporting Standards in Alveolar Ridge Augmentation: A Systematic Review of Clinical Trials.

Europe PMCOriginal source
🇪🇺Researcheuropepmc.orgTier 2 · Direct publisher

Economic Evaluation of Mindfulness-Oriented Recovery Enhancement for the Treatment of Opioid Misuse.

Europe PMCOriginal source